Dysfunctional Pro-Ceramide, ER Stress, and Insulin/IGF Signaling Networks with Progression of Alzheimer's Disease
- 8 June 2012
- journal article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 30 (s2) , S217-S229
Abstract
In Alzheimer's disease (AD), brain insulin and insulin-like growth factor (IGF) resistance and deficiency begin early, and worsen with severity of disease. The factors mediating progression of brain insulin/IGF resistance in AD are not well understooKeywords
This publication has 59 references indexed in Scilit:
- Herp Regulates Hrd1-mediated Ubiquitylation in a Ubiquitin-like Domain-dependent MannerJournal of Biological Chemistry, 2011
- Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegenerationBMC Endocrine Disorders, 2010
- PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's diseaseJournal of Cellular and Molecular Medicine, 2009
- Sphingolipids: players in the pathology of metabolic diseaseTrends in Endocrinology & Metabolism, 2009
- Involvement of Phosphatidylinositol-3 Kinase/AKT/PKCζ/λ Pathway in the Effect of Palmitate on Glucose-Induced Insulin SecretionPancreas, 2008
- Free fatty acids and skeletal muscle insulin resistanceCurrent Opinion in Lipidology, 2008
- Gene Expression Alterations in the Sphingolipid Metabolism Pathways during Progression of Dementia and Alzheimer’s Disease: A Shift Toward Ceramide Accumulation at the Earliest Recognizable Stages of Alzheimer’s Disease?Neurochemical Research, 2007
- The role of inflammation in Alzheimer's diseaseThe International Journal of Biochemistry & Cell Biology, 2005
- Regulation of Insulin Action by CeramideJournal of Biological Chemistry, 2004
- Effects of Insulin on Lipid Metabolism of Larvae and Metamorphosing Landlocked Sea Lamprey,Petromyzon marinusGeneral and Comparative Endocrinology, 1999